<DOC>
	<DOC>NCT00910481</DOC>
	<brief_summary>This study will test the hypothesis that elective use of the Intra-Aortic Balloon Pump (IABP) in patients undergoing high-risk Percutaneous Coronary Intervention (PCI) will reduce the rate of in-hospital major adverse cardiac and cerebrovascular events compared to patients who are managed without planned insertion of IABP.</brief_summary>
	<brief_title>Balloon Pump Assisted Coronary Intervention Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction, Left</mesh_term>
	<criteria>impaired left ventricular function (Ejection Fraction &lt; 30%) large area of myocardium at risk (BCIS1 Myocardial Jeopardy Score â‰¥ 8/12) cardiogenic shock acute STEMI within previous 48 hours complications of recent AMI (including ventricular septal defect, severe mitral regurgitation, intractable ventricular arrhythmias) contraindications to IABP use (including significant iliac or femoral arterial disease and more than mild aortic regurgitation)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Percutaneous Transluminal Coronary Angioplasty</keyword>
	<keyword>Intraaortic Balloon Pumping</keyword>
	<keyword>Left Ventricular Dysfunction</keyword>
	<keyword>High Risk</keyword>
</DOC>